EC publishes recent IMI call evaluation results
The European Commission (EC) has published the results of the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) (stage 2) which closed on 16 May 2018, on its Participant Portal. The evaluation of the second-stage proposals was based upon the three criteria: ‘excellence’, ‘impact’ and ‘quality and efficiency of the implementation’. All seven proposals that were submitted were above threshold, requesting a total budget of € 64,051,532. The European Commission expects that the first grant agreements will be signed by 11 Oct. 2018.